Lipitor Clone Lifts Ranbaxy Laboratories While Pfizer Inc. Bids Drug Goodbye

Pfizer will no longer aggressively market Lipitor (atorvastatin), its former crown jewel and the most lucrative pharmaceutical product ever. At the same time, generic drug manufacturer Ranbaxy posted…
Read the full story: BioSpace.com Featured News